Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 12,590
+220 (1.78%)
Sep 22, 2026, 3:30 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 742.25 billion as of September 22, 2026. Its market cap has decreased by -0.64% in one year.
Market Cap
742.25B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,590.00
ChartMarket Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 742.25B, an increase of 1,712.14%. That is a compound annual growth rate of 9.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 742.25B | -14.87% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Orum Therapeutics | 812.31B |
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |